Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports

NEW YORK, NY June 15, 2015 – Small Cap Profit makes the connection between sophisticated investors and high quality micro and small cap companies that are currently undervalued. We are an issuer of reports written by experienced financial analysts and who provide a straight forward assessment of a profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

*Special Analyst Profile*

Small Cap Profit and several other large media providers will be profiling what should be the biggest alert to date this year.

This is not your ordinary pumped alert with nothing to back it up.

We have done our due diligence and found a diamond in the rough.

This is a NYSE traded stock that has recently given guidance of a 75% increase in revenues that will be reported next week and nobody has seemed to notice.

This is truly a gem that is flying way under the radar and we feel that this could be a 2 or 3 bagger in the very near term.

Be here at 9:45 am EST on Tuesday, June 16, 2015 to be the first to read the full profile:

http://bit.ly/_SpecialProfile

Or if you would like to receive profiles quicker you can text "Profits" to 25827

4 Brief Reports:

Sino Agro Food, Inc. (OTCQB: SIAF) is an agriculture technology and natural food holding company with principal operations in the People's Republic of China.

In the report that follows you will get a description of the company’s operations, share information and read a statement by the company CEO: http://bit.ly/_SIAF_AnalystBrief

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis.

Read about the company’s lead platform candidate for treatment of cancer, DVCax along with updates on clinical trials in this report: http://bit.ly/_NWBO_AnalystBrief

Elite Pharmaceuticals, Inc. (OTCQB: ELTP) is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry.

In the following report read about ELTP’s updates on products it already sells, and an agreement to market its abuse deterrent ELI-200 opioid product: http://bit.ly/_ELTP_AnalystBrief

Anavex Life Sciences Corp. (OTCQX: AVXL) is a biopharmaceutical company that develops novel drug candidates to treat central nervous system (CNS) diseases and various types of cancer.

Read about Anavex’s lead drug candidates for the treatment of Alzheimers and Epilepsy in the report you can get here: http://bit.ly/_AVXL_AnalystBrief

Forward-Looking Disclaimer
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.

Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not engage in high frequency trading or hold any positions of profiled company.
For more information and services provided beyond this release please use contact information provided below. If you notice any errors or omissions, please notify us below.

If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcapprofit.com. For any urgent concerns or inquiries please contact us.

Source: Small Cap Profit
Contact: editor@smallcapprofit.com